系统分子流行病学筛查揭示瑞士HIV队列研究中大量1型人类免疫缺陷病毒重叠感染
基于瑞士HIV队列研究,用22243条HIV-1部分聚合酶序列构建系统发育树,在4575名有纵向序列的参与者中筛查重叠感染,对128例潜在重叠感染行近全长病毒基因组测序,确认52例,估计患病率1%-7%,为迄今最大 confirmed 重叠感染人群。
要点
- 系统发育与距离标准筛查出325例潜在HIV-1重叠感染。
- 128例潜在重叠感染中52例经近全长基因组测序确认,15例未确认,61例采样无法判定。
- 重叠感染虽罕见,患病率1%-7%,但并非可忽略事件。
核心结论
- 基于队列的分子流行病学方法识别出迄今最大 confirmed 重叠感染人群,显示重叠感染虽罕见(患病率1%-7%)但并非可忽略事件。
研究设计与样本
- 利用瑞士HIV队列研究,从22243条HIV-1部分聚合酶序列构建系统发育树,在4575名有纵向序列的参与者中筛查潜在重叠感染,并对生物样本库血浆行近全长病毒基因组测序验证。
主要发现
- 基于系统发育和距离标准,识别出325例潜在HIV-1重叠感染,并按样本误识别导致被检出为重叠感染的可能性分类。
- 对128例潜在重叠感染行近全长病毒基因组测序,其中52例确认、15例未确认、61例因测序样本未包含原筛查中产生重叠感染信号的相关时间点而无法确认或排除。
- 近全长病毒基因组测序可支持67例采样充分的潜在重叠感染中的52例。
关键数值与推荐
- 重叠感染患病率为1%-7%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出检测仍具挑战性,采样频率低且纵向样本不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studying human immunodeficiency virus type 1 (HIV-1) superinfection is important to understand virus transmission, disease progression, and vaccine design. But detection remains challenging, with low sampling frequencies and insufficient longitudinal samples. METHODS: Using the Swiss HIV Cohort Study (SHCS), we developed a molecular epidemiology screening for superinfections. A phylogeny built from 22 243 HIV-1 partial polymerase sequences was used to identify potential superinfections among 4575 SHCS participants with longitudinal sequences. A subset of potential superinfections was tested by near-full-length viral genome sequencing (NFVGS) of biobanked plasma samples. RESULTS: Based on phylogenetic and distance criteria, 325 potential HIV-1 superinfections were identified and categorized by their likelihood of being detected as superinfections due to sample misidentification. NFVGS was performed for 128 potential superinfections; of these, 52 were confirmed by NFVGS, 15 were not confirmed, and for 61 sampling did not allow confirming or rejecting superinfection because the sequenced samples did not include the relevant time points causing the superinfection signal in the original screen. Thus, NFVGS could support 52 of 67 adequately sampled potential superinfections. CONCLUSIONS: This cohort-based molecular approach identified, to our knowledge, the largest population of confirmed superinfections, showing that, while rare with a prevalence of 1%-7%, superinfections are not negligible events.
引用
- Chaudron SE, Leemann C, Kusejko K, et al. A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort Study. J Infect Dis. 2022. PMID: 35485458. doi:10.1093/infdis/jiac166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。